XOMA Royalty has been acquired by Ligand.
For Fiscal Year Ending Dec 31, 2025
For complete information regarding our financials, see our periodic filings
Includes Current Assets, Liabilities and Stockholders' Equity
Includes Total Net Sales, Cost & Expenses and Earnings per share
Includes Net Income, Adjustments, and Cash flows from investing & financing activities